Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease

CEA, CA19-9 and CA50 are tumour associated antigens defined by monoclonal antibodies which have been raised against adenocarcinoma cell lines. The aim of this study was to determine whether their combined use could improve diagnostic accuracy in patients with primary and secondary liver tumours. An...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lucarotti, M. E., Rothnie, N. D., Kelly, S. B., Hershman, M. J., Johanssen, C., Nilsson, O., Lindholm, L., Wood, C. B., Williamson, R. C. N., Habib, N. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 1991
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442938/
https://ncbi.nlm.nih.gov/pubmed/1777407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/1991/23874
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados